Two Sigma Advisers’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,100
| Closed | -$1.14M | – | 2371 |
|
|
2024
Q4 | $1.14M | Buy |
41,100
+27,200
| +196% | +$757K | ﹤0.01% | 1396 |
|
|
2024
Q3 | $399K | Sell |
13,900
-4,200
| -23% | -$120K | ﹤0.01% | 1797 |
|
|
2024
Q2 | $425K | Buy |
+18,100
| New | +$425K | ﹤0.01% | 1952 |
|
|
2023
Q2 | – | Sell |
-18,200
| Closed | -$696K | – | 2372 |
|
|
2023
Q1 | $696K | Sell |
18,200
-2,900
| -14% | -$111K | ﹤0.01% | 1804 |
|
|
2022
Q4 | $1.16M | Buy |
+21,100
| New | +$1.16M | ﹤0.01% | 1509 |
|
|
2022
Q3 | – | Sell |
-22,200
| Closed | -$210K | – | 2529 |
|
|
2022
Q2 | $210K | Sell |
22,200
-2,400
| -10% | -$22.7K | ﹤0.01% | 2258 |
|
|
2022
Q1 | $349K | Sell |
24,600
-14,400
| -37% | -$204K | ﹤0.01% | 2158 |
|
|
2021
Q4 | $825K | Sell |
39,000
-41,400
| -51% | -$876K | ﹤0.01% | 1659 |
|
|
2021
Q3 | $1.8M | Sell |
80,400
-59,900
| -43% | -$1.34M | ﹤0.01% | 1316 |
|
|
2021
Q2 | $3.48M | Sell |
140,300
-29,400
| -17% | -$729K | 0.01% | 1034 |
|
|
2021
Q1 | $4.92M | Buy |
169,700
+35,900
| +27% | +$1.04M | 0.01% | 857 |
|
|
2020
Q4 | $3.45M | Buy |
133,800
+121,900
| +1,024% | +$3.14M | 0.01% | 981 |
|
|
2020
Q3 | $366K | Buy |
+11,900
| New | +$366K | ﹤0.01% | 1939 |
|